Philips and Singapore General Hospital (SGH) to establish Digital and Computational Pathology Center of Excellence
Digital pathology at Singapore General Hospital
October 23, 2020
SGH aims to develop the first fully digitized histopathology laboratory in ASEAN by expanding the use of Philips’ IntelliSite Pathology Solution, potentially increasing the productivity of existing staff by 7%
Philips Singapore and SGH will optimize digital pathology use to facilitate research in Artificial Intelligence (AI)
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a collaboration with Singapore General Hospital (SGH) to establish the Singapore General Hospital Digital and Computational Pathology Center of Excellence. The SGH Center of Excellence aims to advance pathology practice by implementing a fully digital histopathology workflow and deploying Artificial Intelligence (AI) to increase productivity and enhance patient care.
Located within SGH’s Division of Pathology, one of the largest pathology laboratories in ASEAN, the Center of Excellence aims to establish ASEAN’s first fully digitized histopathology laboratory by expanding its digital pathology capabilities for primary diagnosis, training, and R&D with the Philips IntelliSite Pathology Solution. Both SGH and Philips will also work closely on other diverse areas, including streamlining of the histopathology laboratory’s digital workflow.
As in other parts of the world, the demand for cancer diagnosis in Singapore is increasing while pathologists remain scarce. A recent study, conducted by SGH and Philips, revealed that full digitization of SGH’s histopathology laboratory will improve efficiency. It has the potential to enable time savings in the pathology workflow and allow the pathology department to increase its capacity by another 7% whilst retaining the same number of employees.
Through optimization of digital pathology at SGH, the hospital will be able to further its research in AI. AI-based tools can aid pathologists in diagnosing diseases such as cancer – the leading cause of mortality in Singapore  – and empower them to face the current challenges in pathology. The increasing number of cancer cases, an aging population, and rapid advances in personalized medicine have resulted in significant complexity of pathological diagnostics, adding to the workload of pathologists. AI will allow pathologists to focus more on challenging tasks and unusual cases that require a higher degree of expertise and skills.
“As healthcare becomes more complex and demanding, digitization has become a key enabler for the Hospital to provide better care for our patients and to be more efficient,” said Prof. Kenneth Kwek, Chief Executive Officer at SGH. “Digital pathology is an example of that. Our partnership with companies such as Philips, with its clinical and technical know-how, is important in helping us achieve our goal.”
“Digital pathology enhances the quality and efficiency of a histopathology laboratory,” said Diederik Zeven, General Manager, Health Systems, Philips ASEAN Pacific. “We are committed to partnering with leading healthcare institutions like Singapore General Hospital to bring the latest in precision diagnosis and AI capabilities to help them augment clinical quality, improving patient outcomes and thereby reducing the cost of care.”
Philips IntelliSite Pathology Solution enables pathologists to review and interpret digital images of surgical pathology
Oct. 21 (UPI) — U.S. Surgeon General Dr. Jerome Adams joined other top health experts Wednesday in opposing a dangerous “herd immunity” strategy, as the United States again added another 60,000 COVID-19 cases.
According to updated data from Johns Hopkins University, there were 60,300 new cases nationwide on Tuesday — the third time in the past week that the level has topped 60,000.
Deaths in the United States also increased on Tuesday, the data showed, to more than 900. Since the start of the pandemic, there have been 8.28 million cases and about 221,100 deaths nationwide.
Wednesday, Adams joined Dr. Antony Fauci and other top health officials in opposing a herd immunity strategy, which is purportedly being considered by the Trump administration. Adams said pursuing such a strategy, which effectively allows the coronavirus to spread unchecked, would result in an unacceptable death toll.
Adams tweeted that there’s no “example of a large-scale successful intentional infection-based herd immunity strategy” and warned that the course would “lead to many complications/deaths.”
The strategy reasons that letting the virus spread would infect large populations, who would then develop a natural immunity to COVID-19 and thereby reduce the number of people who can be infected afterward. Eventually, the theory goes, the virus would run into a dead end.
“Large numbers of people would need to be infected to achieve herd immunity without a vaccine,” Adams wrote, warning that such a path could “overwhelm” healthcare systems.
Fauci, director of the National Institute of Allergy and Infectious Diseases, rejected the idea of herd immunity last week, calling it “ridiculous” and “total nonsense.”
Most scientists say there would be no feasible way to isolate and protect vulnerable Americans who face a greater risk of death from COVID-19 in such a scenario.
Researchers at the University of Washington say a herd immunity strategy would likely lead to tens of thousands of additional deaths by the start of 2021.
Child cases have increased by almost 15% — 84,000 cases — in the first two weeks of October, according to an update from the American Academy of Pediatrics and Children’s Hospital Association.
Since the start of the crisis, about 740,000 children have tested positive in the United States — almost 11% of total cases, it said. The overall infection rate is 986 per 100,000 children.
Though severe illness and deaths still appear to be rare among children, the groups urged authorities to “provide detailed reports on COVID-19 cases, testing, hospitalizations and mortality by age and race/ethnicity so that the effects of COVID-19 on children’s health can be documented and monitored.”
The Centers for Disease Control and Prevention said Tuesday there have been about 300,000 deaths more than normal so far this year due to the pandemic.
In a typical year, the CDC said, there are about 1.9 million deaths from all causes between February and October. This year, COVID-19 has pushed that figure to near 2.2 million, an increase of 14.5%.
About 200,000 of the extra deaths may be attributed to